Pharmaceutical companies will spend hundreds of millions getting a drug to market. And manage their process R&D data in Excel.
Pharmaceutical companies will spend hundreds of millions getting a drug to market. And manage their process R&D data in Excel.
In an industry where a single data point can determine whether a drug reaches a patient fast enough - that is worth paying attention to.
In the last few months, across conversations with process chemists and heads of process development, I keep hearing the same story - told differently every time:
- Critical process parameters buried in spreadsheets nobody can locate
- Scale-up decisions made from a PDF buried in a 47-reply email chain
- Decades of institutional knowledge sitting in the head of one senior chemist who retires in 3 years
The science these teams are doing is extraordinary.
The infrastructure holding it together is not. In many companies, critical process decisions live in PDFs, spreadsheets, and email threads.
And the cost isn't just operational. Failed experiments, repeated work, slow scale-up decisions. The teams that treat their process R&D data as a strategic asset will move faster, make better decisions, and reach manufacturing readiness in a fraction of the time.
That gap is only going to widen.
This is exactly why we built ReactWise - not because the chemistry was broken, but because the systems around the chemistry were.
We're not here to replace process chemists.
We're here to make sure their best decisions don't get lost in someone's inbox.
If you've been in that email chain - I'd love to show you how we're tackling it.
